ella

About Ella Korets-Smith

This author has not yet filled in any details.
So far Ella Korets-Smith has created 7 blog entries.

ADVANCED PROTEOME THERAPEUTICS ANNOUNCES 2017 AGM RESULTS AND CORPORATE UPDATE

2017-08-03T19:22:56+00:00

VANCOUVER, BC--(Marketwired - July 31, 2017) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) a biotechnology company focused on developing superior targeted protein therapeutics, today announced the election of its board of directors from its Annual General Meeting (the "AGM") of shareholders, held on Wednesday July 26, 2017. Shareholders [...]

ADVANCED PROTEOME THERAPEUTICS ANNOUNCES 2017 AGM RESULTS AND CORPORATE UPDATE 2017-08-03T19:22:56+00:00

ADVANCED PROTEOME THERAPEUTICS ANNOUNCES COLLABORATION TO DEVELOP CANCER THERAPEUTIC

2017-08-03T19:22:05+00:00

VANCOUVER, BC--(Marketwired - July 18, 2017) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) a biotechnology company focused on developing superior targeted protein therapeutics is pleased to announce a collaboration with the National Research Council of Canada (NRC). Through this arrangement both parties have forged a strategic relationship to [...]

ADVANCED PROTEOME THERAPEUTICS ANNOUNCES COLLABORATION TO DEVELOP CANCER THERAPEUTIC 2017-08-03T19:22:05+00:00

ADVANCED PROTEOME THERAPEUTICS CORPORATION COMPLETED RIGHTS OFFERING FOR GROSS PROCEEDS OF APPROXIMATELY $430,000

2017-08-03T19:20:32+00:00

VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 11, 2017) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE:APC)(FRANKFURT:0E8) is pleased to report that it has completed its previously announced rights offering (the "Rights Offering"). Under the Rights Offering, on July 10, 2017, 7,136,216 units of the Corporation (the "Units") were distributed at a price of $0.06 per Unit for gross [...]

ADVANCED PROTEOME THERAPEUTICS CORPORATION COMPLETED RIGHTS OFFERING FOR GROSS PROCEEDS OF APPROXIMATELY $430,000 2017-08-03T19:20:32+00:00

ADVANCED PROTEOME THERAPEUTICS ANNOUNCES RIGHTS OFFERING

2017-08-03T19:18:41+00:00

VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 1, 2017) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE:APC)(FRANKFURT:0E8) is pleased to announce that it will conduct a rights offering to raise gross proceeds of up to $1,900,281 (the "Rights Offering"). Under the Rights Offering, the Company will be offering transferable rights (the "Rights") to holders of its [...]

ADVANCED PROTEOME THERAPEUTICS ANNOUNCES RIGHTS OFFERING 2017-08-03T19:18:41+00:00

ADVANCED PROTEOME THERAPEUTICS ADVANCES COLLABORATIONS

2017-08-03T19:16:42+00:00

VANCOUVER, BC--(Marketwired - May 18, 2017) - Advanced Proteome Therapeutics Corporation (APC) (TSX VENTURE: APC) (FRANKFURT: 0E8), a biotechnology company focused on producing technologies to perfect the use of antibody drug conjugates for the treatment of various cancers is pleased to announce they are progressing collaborations to translate their site-selective chemistries into high value antibody [...]

ADVANCED PROTEOME THERAPEUTICS ADVANCES COLLABORATIONS 2017-08-03T19:16:42+00:00

ADVANCED PROTEOME THERAPEUTICS CORPORATION ANNOUNCES LAUNCH OF NEW CORPORATE WEBSITE

2017-08-03T19:13:19+00:00

Vancouver, British Columbia, May 3rd, 2017 – Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSX VENTURE: APC) (Frankfurt: 0E8) a biotechnology company focused on producing technologies to perfect the use of antibody drug conjugates for the treatment of various cancers is pleased to announce the launch of their new website. The website is now [...]

ADVANCED PROTEOME THERAPEUTICS CORPORATION ANNOUNCES LAUNCH OF NEW CORPORATE WEBSITE 2017-08-03T19:13:19+00:00

Advanced Proteome Therapeutics Moves Into Johnson & Johnson Innovation, JLABS @ Toronto

2017-05-03T16:56:03+00:00

VANCOUVER, BC--(May 01, 2017) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8), a biotechnology company focused on producing technologies to perfect the use of antibody drug conjugates for the treatment of various cancers, is pleased to announce it has been accepted into Johnson & Johnson Innovation, JLABS @ Toronto. [...]

Advanced Proteome Therapeutics Moves Into Johnson & Johnson Innovation, JLABS @ Toronto 2017-05-03T16:56:03+00:00